Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00SMU
|
|||
| Former ID |
DIB000695
|
|||
| Drug Name |
Lenti-D
|
|||
| Synonyms |
Adrenoleukodystrophy gene therapy, INSERM/Genetix; CCALD program (cerebral adrenoleukodystrophy), INSERM/bluebird; Genetically-modified stem cell therapy (adrenoleukodystrophy), INSERM/bluebird
Click to Show/Hide
|
|||
| Indication | Adrenoleukodystrophy [ICD-11: 8A44.1] | Phase 3 | [1] | |
| Company |
Bluebird bio
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03852498) A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.